Clayton, Dubilier & Rice, LLC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$725.0M2026 Q3
Positions4
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Clayton, Dubilier & Rice, LLC reported 4 positions worth $725.0M as of September 30, 2026 (13F filed November 12, 2026). Largest holding: AGL (43.9%).

4 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AGLagilon health$318.4M43.91%4,000,000——+46.7%
▸ 2 REZIResideo Technologies$272.1M37.53%14,991,916——+20.1%
▸ 3 ADIGAdi Global Distribution$134.3M18.53%7,495,958——-43.7%
▸ 4 CMCOColumbus Mckinnon$241.8K0.03%15,180——+28.8%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Clayton, Dubilier & Rice, LLC hold as of Q3 2026?

Clayton, Dubilier & Rice, LLC reported 4 positions worth $725.0M in its Q3 2026 13F filing. Largest positions: AGL (43.9%), REZI (37.5%), ADIG (18.5%) and CMCO (0.0%).

What did Clayton, Dubilier & Rice, LLC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Clayton, Dubilier & Rice, LLC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.